Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study

Fecha de publicación: 24/12/2014

Autores de IIS La Fe

• Ana Rosa Cid Haro

  Autor

• Victor Vicente Vilas

  Autor

Participantes ajenos a IIS La Fe

• Sánchez-Guiu I
• Antón AI
• Padilla J
• Velasco F
• Lucia JF
• Lozano M
• Sevivas T
• Lopez-Fernandez MF
• González-Manchón C
• Rivera J
• Lozano ML

Grupos

• Hemostasia, Trombosis, Arteriosclerosis y Biología vascular

  

  Investigador Principal

  Pilar Medina Badenes

Abstract

Background: The diagnostic evaluation of inherited platelet disorders (IPDs) is complicated and time-consuming, resulting in a relevant number of undiagnosed and incorrectly classified patients. In order to evaluate the spectrum of IPDs in individuals with clinical suspicion of these disorders, and to provide a diagnostic tool to centers not having access to specific platelets studies, we established the project "Functional and Molecular Characterization of Patients with Inherited Platelet Disorders" under the scientific sponsorship of the Spanish Society of Thrombosis and Haemostasis. Patients/methods: Subjects were patients from a prospective cohort of individuals referred for clinical suspicion of IPDs as well as healthy controls. Functional studies included light transmission aggregation, flow cytometry, and when indicated, Western-blot analysis of platelet glycoproteins, and clot retraction analysis. Genetic analysis was mainly performed by sequencing of coding regions and proximal regulatory regions of the genes of interest. Results: Of the 70 cases referred for study, we functionally and molecularly characterized 12 patients with Glanzmann Thrombasthenia, 8 patients with Bernard Soulier syndrome, and 8 with other forms of IPDs. Twelve novel mutations were identified among these patients. The systematic study of patients revealed that almost one-third of patients had been previously misdiagnosed. Conclusions: Our study provides a global picture of the current limitations and access to the diagnosis of IPDs, identifies and confirms new genetic variants that cause these disorders, and emphasizes the need of creating reference centers that can help health care providers in the recognition of these defects.

Keywords

• Bernard Soulier syndrome; Glanzmann thrombasthenia; Inherited platelet disorders; Chediak-Higashi syndrome; Hermansky Pudlak syndrome; ANKRD26; Congenital amegakaryocytic thrombocytopenia